Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells. (March 2021)

• Record Type: Journal Article
• Authors: Mahmoudi, Reza; Hassandokht, Fatemeh; Ardakani, Maryam Tajali; Karimi, Bahman; Roustazadeh, Abazar; Tarvirdipour, Shabnam; Barmak, Mehzad Jafari; Nikseresht, Mohsen; Baneshi, Marzieh; Mousavizadeh, Ali; Shirazi, Mohsen Saghebray; Alipour, Mohsen; Bardania, Hassan
• Is Part Of: Journal of biomaterials applications. Volume 35:Number 8(2021)
• Page Start: 1005
• Page End: 1018
• Publication Date: 2021-03
• Subjects: Curcumin -- liposome -- cytotoxicity -- breast cancer -- apoptosis assays; Biomedical engineering -- Periodicals; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1177/0885328220976331
• Languages: English
• ISSNs: 0885-3282

Abstract

Resistance to common chemotherapeutic agents is a frequent phenomenon in late-stage breast cancers. An ideal system capable of the co-delivery of hydrophobic and hydrophilic chemotherapeutic agents can regulate the dosage and co-localization of pharmaceutical compounds and thereby improve the anticancer efficacy. Here, for the first time, we have intercalated curcumin (Cur) into a double-layered membrane of cisplatin (Cis) liposomes to obtain a dosage controlled co-delivery formulation, capable of inducing apoptosis in breast cancer cells. The concentrations of Cur and Cis in nanoliposome (Cur-Cis@NLP) were optimized by response surface methodology (RSM); RSM optimization showed 99.81 and 23.86% entrapment efficiency for Cur and Cis, respectively. TEM analysis demonstrated the fabrication of nanoparticles with average diameter of 100 nm. The anticancer and apoptotic effects of Cur-Cis@NLPs were also evaluated using MTT assay, fluorescent staining and flow cytometry assays. Cytotoxicity assessments of various Cur-Cis@NLPs concentrations demonstrated a concentration-dependent manner. In comparison to free and liposomal Cis, Cur-Cis@NLP reduced breast cancer cells' viability (82.5%) in a significant manner at a final concentration of 32 μg.mL −1 and 20 μg.mL −1 of Cur and Cis, respectively. Combination index values calculation of Cur-Cis@NLP showed an overall CI value <1, indicating synergetic effect of the designed co-delivery system. Additionally, flow cytometry assay demonstrated Cur-Cis@NLPs triggered apoptosis about 10-folds higher than liposomal Cis. This co-drug delivery system has a potential for the encapsulation and release of both hydrophobic and hydrophilic drugs, while taking the advantages of the reduced cytotoxic effect along with achieving high potency.